Advanced search
Publication Cover
Journal of Medical Economics Volume 14, 2011 - Issue 2
Submit an article Journal homepage
750
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer

Josh J. Carlson University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USACorrespondence[email protected]
,
William B. Wong University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA
,
David L. Veenstra University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA
&
Carolina Reyes Genentech, Inc. South San Francisco, CA, USA
Pages 159-166 | Accepted 19 Jan 2011, Published online: 24 Mar 2011

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Daniel Resende Faleiros, Juliana Álvares, Alessandra Maciel Almeida, Vânia Eloisa de Araújo, Eli Iola Gurgel Andrade, Brian B. Godman, Francisco A. Acurcio & Augusto A. Guerra Júnior. (2016) Budget impact analysis of medicines: updated systematic review and implications. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 257-266.
Read now
Chan Shen, Chun-Ru Chien, Daniel M Geynisman, Fabrice Smieliauskas & Ya-Chen T Shih. (2014) A review of economic impact of targeted oral anticancer medications. Expert Review of Pharmacoeconomics & Outcomes Research 14:1, pages 45-69.
Read now
Kai Yeung & Josh J Carlson. (2012) Clinical and economic review of erlotinib in non-small-cell lung cancer. Expert Review of Pharmacoeconomics & Outcomes Research 12:4, pages 411-423.
Read now

Articles from other publishers (7)

Luis HernandezMelanie Young. (2023) The budget impact of introducing mobocertinib for the postplatinum treatment of advanced non–small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations. Journal of Managed Care & Specialty Pharmacy 29:2, pages 172-186.
Crossref
Lu Han, Xin Zhang, Wen-Qi Fu, Cheng-Yao Sun, Xian-Ming Zhao, Liang-Ru Zhou & Guo-Xiang Liu. (2020) A systematic review of the budget impact analyses for antitumor drugs of lung cancer. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Daniel StellatoMargaret E. GerbasiBriana NdifeSameer R. GhateAaron MoynahanDinesh MishraPraveen GundaRoy KoruthThomas E. Delea. (2019) Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer Perspective. Journal of Managed Care & Specialty Pharmacy 25:11, pages 1227-1237.
Crossref
Maurice Perol, Heather Wakelee & Luis Paz-Ares. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology 448 465.e4 .
Josephine Mauskopf & Stephanie Earnshaw. (2016) A Methodological Review of US Budget-Impact Models for New Drugs. PharmacoEconomics 34:11, pages 1111-1131.
Crossref
Nataniel H. Lester-Coll, Charles E. Rutter, Trevor J. Bledsoe, Sarah B. Goldberg, Roy H. Decker & James B. Yu. (2016) Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases. International Journal of Radiation Oncology*Biology*Physics 95:2, pages 663-672.
Crossref
Shun Lu & Yong-feng Yu. (2011) Maintenance therapy for NSCLC: Consensus and controversy. Chinese Journal of Cancer Research 23:4, pages 254-258.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.